Xconomy’s Digital Events →
August 18th, 2016
Xconomy Boston —
Cambridge, MA-based RNA drug developer Wave Life Sciences (NASDAQ: WVE) has named Keith Regnante its chief financial officer. Regnante was previously the VP of finance at Shire, and had stints at Biogen and Boston Consulting Group before that.
Join us on July 16 for a special two-part gathering that will take a unique and critical look at the Internet today, and where it is heading.
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
Sponsored · Whitepaper
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
What the most successful life sciences fundraising pitch decks all have in common